210 related articles for article (PubMed ID: 15363952)
1. In vitro characterization of AR-A000002, a novel 5-hydroxytryptamine(1B) autoreceptor antagonist.
Ahlgren C; Eriksson A; Tellefors P; Ross SB; Stenfors C; Malmberg A
Eur J Pharmacol; 2004 Sep; 499(1-2):67-75. PubMed ID: 15363952
[TBL] [Abstract][Full Text] [Related]
2. Behavioral pharmacology of AR-A000002, a novel, selective 5-hydroxytryptamine(1B) antagonist.
Hudzik TJ; Yanek M; Porrey T; Evenden J; Paronis C; Mastrangelo M; Ryan C; Ross S; Stenfors C
J Pharmacol Exp Ther; 2003 Mar; 304(3):1072-84. PubMed ID: 12604684
[TBL] [Abstract][Full Text] [Related]
3. Pharmacology of a novel selective 5-hydroxytryptamine1B receptor antagonist, AR-A000002.
Stenfors C; Hallerbäck T; Larsson LG; Wallsten C; Ross SB
Naunyn Schmiedebergs Arch Pharmacol; 2004 Mar; 369(3):330-7. PubMed ID: 14758468
[TBL] [Abstract][Full Text] [Related]
4. [N-methyl-3H3]AZ10419369 binding to the 5-HT1B receptor: in vitro characterization and in vivo receptor occupancy.
Maier DL; Sobotka-Briner C; Ding M; Powell ME; Jiang Q; Hill G; Heys JR; Elmore CS; Pierson ME; Mrzljak L
J Pharmacol Exp Ther; 2009 Jul; 330(1):342-51. PubMed ID: 19401496
[TBL] [Abstract][Full Text] [Related]
5. SB-224289--a novel selective (human) 5-HT1B receptor antagonist with negative intrinsic activity.
Selkirk JV; Scott C; Ho M; Burton MJ; Watson J; Gaster LM; Collin L; Jones BJ; Middlemiss DN; Price GW
Br J Pharmacol; 1998 Sep; 125(1):202-8. PubMed ID: 9776361
[TBL] [Abstract][Full Text] [Related]
6. SB-616234-A (1-[6-(cis-3,5-dimethylpiperazin-1-yl)-2,3-dihydro-5-methoxyindol-1-yl]-1-[2'methyl-4'-(5-methyl-1,2,3-oxadiazol-3-yl)biphenyl-4-yl]methanone hydrochloride): a novel, potent and selective 5-HT1B receptor antagonist.
Scott C; Langmead CJ; Clarke KL; Wyman P; Smith PW; Starr KR; Dawson LA; Price GW; Hagan JJ; Watson J
Neuropharmacology; 2006 Jun; 50(8):984-90. PubMed ID: 16546225
[TBL] [Abstract][Full Text] [Related]
7. SB-272183, a selective 5-HT(1A), 5-HT(1B) and 5-HT(1D) receptor antagonist in native tissue.
Watson J; Roberts C; Scott C; Kendall I; Collin L; Day NC; Harries MH; Soffin E; Davies CH; Randall AD; Heightman T; Gaster L; Wyman P; Parker C; Price GW; Middlemiss DN
Br J Pharmacol; 2001 Jul; 133(6):797-806. PubMed ID: 11454652
[TBL] [Abstract][Full Text] [Related]
8. In vitro activity of LY393558, an inhibitor of the 5-hydroxytryptamine transporter with 5-HT(1B/1D/2) receptor antagonist properties.
Pullar IA; Boot JR; Carney SL; Cohen ML; Colvin EM; Conway RG; Hardy CH; Lucaites VL; Nelson DL; Schenck KW; Tomlinson R; Wedley S
Eur J Pharmacol; 2001 Nov; 432(1):9-17. PubMed ID: 11734182
[TBL] [Abstract][Full Text] [Related]
9. 5-Hydroxytryptamine1B receptor-mediated contraction of rabbit saphenous vein and basilar artery: role of vascular endothelium.
Bhattacharya A; Schenck KW; Xu YC; Nisenbaum L; Galbreath E; Cohen ML
J Pharmacol Exp Ther; 2004 May; 309(2):825-32. PubMed ID: 14724223
[TBL] [Abstract][Full Text] [Related]
10. SB-649915, a novel, potent 5-HT1A and 5-HT1B autoreceptor antagonist and 5-HT re-uptake inhibitor in native tissue.
Scott C; Soffin EM; Hill M; Atkinson PJ; Langmead CJ; Wren PB; Faedo S; Gordon LJ; Price GW; Bromidge S; Johnson CN; Hagan JJ; Watson J
Eur J Pharmacol; 2006 Apr; 536(1-2):54-61. PubMed ID: 16571351
[TBL] [Abstract][Full Text] [Related]
11. Autoradiographic characterisation of [35S]GTPgammaS binding stimulation mediated by 5-HT1B receptor in postmortem human brain.
Mostany R; Pazos A; Castro ME
Neuropharmacology; 2005 Jan; 48(1):25-33. PubMed ID: 15617724
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological analysis of G-protein activation mediated by guinea-pig recombinant 5-HT1B receptors in C6-glial cells: similarities with the human 5-HT1B receptor.
Pauwels PJ; Wurch T; Palmier C; Colpaert FC
Br J Pharmacol; 1998 Jan; 123(1):51-62. PubMed ID: 9484854
[TBL] [Abstract][Full Text] [Related]
13. The selective 5-HT1B receptor inverse agonist 1'-methyl-5-[[2'-methyl-4'-(5-methyl-1,2, 4-oxadiazol-3-yl)biphenyl-4-yl]carbonyl]-2,3,6,7-tetrahydro- spiro[furo[2,3-f]indole-3,4'-piperidine] (SB-224289) potently blocks terminal 5-HT autoreceptor function both in vitro and in vivo.
Gaster LM; Blaney FE; Davies S; Duckworth DM; Ham P; Jenkins S; Jennings AJ; Joiner GF; King FD; Mulholland KR; Wyman PA; Hagan JJ; Hatcher J; Jones BJ; Middlemiss DN; Price GW; Riley G; Roberts C; Routledge C; Selkirk J; Slade PD
J Med Chem; 1998 Apr; 41(8):1218-35. PubMed ID: 9548813
[TBL] [Abstract][Full Text] [Related]
14. The role of the 5-HT1D receptor as a presynaptic autoreceptor in the guinea pig.
Pullar IA; Boot JR; Broadmore RJ; Eyre TA; Cooper J; Sanger GJ; Wedley S; Mitchell SN
Eur J Pharmacol; 2004 Jun; 493(1-3):85-93. PubMed ID: 15189767
[TBL] [Abstract][Full Text] [Related]
15. F 11356, a novel 5-hydroxytryptamine (5-HT) derivative with potent, selective, and unique high intrinsic activity at 5-HT1B/1D receptors in models relevant to migraine.
John GW; Pauwels PJ; Perez M; Halazy S; Le Grand B; Verscheure Y; Valentin JP; Palmier C; Wurch T; Chopin P; Marien M; Kleven MS; Koek W; Assie MB; Carilla-Durand E; Tarayre JP; Colpaert FC
J Pharmacol Exp Ther; 1999 Jul; 290(1):83-95. PubMed ID: 10381763
[TBL] [Abstract][Full Text] [Related]
16. Molecular cloning, pharmacological properties and tissue distribution of the porcine 5-HT(1B) receptor.
Bhalla P; Sharma HS; Ma X; Wurch T; Pauwels PJ; Saxena PR
Br J Pharmacol; 2001 Jul; 133(6):891-901. PubMed ID: 11454663
[TBL] [Abstract][Full Text] [Related]
17. 5-Hydroxytryptamine(1F) receptors do not participate in vasoconstriction: lack of vasoconstriction to LY344864, a selective serotonin(1F) receptor agonist in rabbit saphenous vein.
Cohen ML; Schenck K
J Pharmacol Exp Ther; 1999 Sep; 290(3):935-9. PubMed ID: 10454462
[TBL] [Abstract][Full Text] [Related]
18. Designing selective, high affinity ligands of 5-HT1D receptor by covalent dimerization of 5-HT1F ligands derived from 4-fluoro-N-[3-(1-methyl-4-piperidinyl)-1H-indol-5-yl]benzamide.
Choi SK; Green D; Ho A; Klein U; Marquess D; Taylor R; Turner SD
J Med Chem; 2008 Jun; 51(12):3609-16. PubMed ID: 18507369
[TBL] [Abstract][Full Text] [Related]
19. Evidence for presynaptic location of inhibitory 5-HT1D beta-like autoreceptors in the guinea-pig brain cortex.
Bühlen M; Fink K; Böing C; Göthert M
Naunyn Schmiedebergs Arch Pharmacol; 1996 Feb; 353(3):281-9. PubMed ID: 8692282
[TBL] [Abstract][Full Text] [Related]
20. Effects of long-term administration of the 5-hydroxytryptamine1B receptor antagonist AR-A000002 to guinea pigs.
Stenfors C; Ahlgren C; Yu H; Wedén M; Larsson LG; Ross SB
Psychopharmacology (Berl); 2004 Mar; 172(3):333-40. PubMed ID: 14652708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
